In Switzerland, there are several studies that include human biomonitoring. However, these do not yet provide data representative of Switzerland, so a national study is being considered. Now the first results are available
of the pilot study.
Autoren
- Leoni Burggraf
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Lung cancer
Perioperative therapy for better efficacy
- Alzheimer
Simplification and support of diagnostics through blood tests
- Primary biliary cholangitis
Therapy slows down liver damage
- Rheumatoid arthritis
Using predictors to improve therapy management
- Post-COVID
Complaints from a neurological point of view
- Type 2 diabetes, high blood pressure and cardiovascular risk
SGLT2 inhibitors are also a matter of the heart
- Clinical suspicion of Borrelia infection
When is a serological clarification useful?
- Tumor breakthrough pain